Policy Issues: Filing of Supplemental New Drug Submissions, Supplemental Abbreviated New Drug Submissions, Notifiable Changes and Cross-referenced Submissions

Policy Issues: Filing of Supplemental New Drug Submissions, Supplemental Abbreviated New Drug Submissions, Notifiable Changes and Cross-referenced Submissions The attached policy has been developed to provide for the filing of Supplemental New Drug Submissions, Supplemental Abbreviated New Drug Submissions, Notifiable Changes and Cross-Referenced Submissions in some circumstances prior to the issuance of the Notice of Compliance for the original submission. 2023-09-03 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetypolicy issuessupplemental new-drug-submissionssupplemental abbreviated-new-drug-submissionschanges-and-cross-referenced submissions Policy Issues: Filing of Supplemental New Drug Submissions, Supplemental Abbreviated New Drug Submissions, Notifiable Changes and Cross-referenced SubmissionsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/policies/policy-issues-filing-supplemental-new-drug-submissions-supplemental-abbreviated-new-drug-submissions-notifiable-changes-cross-referenced-submissions.html Policy Issues: Filing of Supplemental New Drug Submissions, Supplemental Abbreviated New Drug Submissions, Notifiable Changes and Cross-referenced SubmissionsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/politiques/questions-politique-depot-presentations-supplementaires-drogues-nouvelles-supplements-presentation-abregee-drogue-nouvelle-modifications-declaration.html

The attached policy has been developed to provide for the filing of Supplemental New Drug Submissions, Supplemental Abbreviated New Drug Submissions, Notifiable Changes and Cross-Referenced Submissions in some circumstances prior to the issuance of the Notice of Compliance for the original submission.

Data and Resources

Similar records